Prognostic stratification of resected pancreatic ductal adenocarcinoma: Past, present, and future
- 1 October 2018
- journal article
- review article
- Published by Elsevier in Digestive and Liver Disease
- Vol. 50 (10) , 979-990
Abstract
No abstract availableKeywords
This publication has 132 references indexed in Scilit:
- Signatures of mutational processes in human cancerNature, 2013
- EMT and Dissemination Precede Pancreatic Tumor FormationCell, 2012
- Genetic evolution of pancreatic cancer: lessons learnt from the pancreatic cancer genome sequencing projectGut, 2011
- Meta-analysis of immunohistochemical prognostic markers in resected pancreatic cancerBritish Journal of Cancer, 2011
- Re‐evaluating the impact of tumor size on survival following pancreaticoduodenectomy for pancreatic adenocarcinomaJournal of Surgical Oncology, 2011
- Does the Mechanism of Lymph Node Invasion Affect Survival in Patients with Pancreatic Ductal Adenocarcinoma?Journal of Gastrointestinal Surgery, 2009
- The Lymph Node Ratio is the Strongest Prognostic Factor after Resection of Pancreatic CancerJournal of Gastrointestinal Surgery, 2009
- Long-Term Survival and Prognostic Indicators in Small (≤2 cm) Pancreatic CancerPancreatology, 2008
- Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic AnalysesScience, 2008
- REporting recommendations for tumour MARKer prognostic studies (REMARK)British Journal of Cancer, 2005